Advanced Search
Disease Phase
Title Drug
Clinical Trials Listing
  • < Previous
  • 1
  • Next >
  • Penn Treatment Trials (8)
  • Penn Non-Treatment Trials (6)
  • Phase 1: Solid Tumor Trials (2)
  • Proton Therapy Trials (3)
Active treatment trials at Penn's Abramson Cancer Center
Protocol ID Title Phase Modality Drug
HCC-P3-11-01 Phase 3 Prospective, Randomized, Blinded, and Controlled Investigation of HepaSphere/QuadraSphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Carcinoma III Chemotherapy doxorubicin
POLARIS2009-001 A Randomized, Double-Blind, Multi-Center Phase 3 Study of ADI-PEG 20 Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Subjects With Advanced Hepatocellular Carcinoma (HCC) Who Have Failed Prior Systemic Therapy III Biological Therapy pegylated arginine deiminase
09-131 Phase II Study of Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma II Proton Therapy Not Applicable
A4061058 A Multicenter, Global, Randomized, Double-Blind Study Of Axitinib Plus Best Supportive Care Versus Placebo Plus Best Supportive Care In Patients With Advanced Hepatocellular Carcinoma Following Failure Of One Prior Antiangiogenic Therapy II Supportive Care, Signal Transduction Inhibitor axitinib
UPCC - 13212 A Phase 1 Study of LY2801653 in Patients With Advanced Cancer I c-MET Inhibitor LY2801653
CA186-011 A Phase 1 Study of the Safety, Tolerability, Pharmacokinetics and Immunoregulatory Activity of BMS-663513 (Anti-CD137) in Subjects With Advanced and/or Metastatic Solid Tumors I Immunotherapy BMS-663513
UPCC 09211 A Feasibility and Registration Study of Proton Radiotherapy for Upper Gastrointestinal Malignancies Not Specified Radiotherapy, Proton Therapy Not Applicable
A2ALL Core Protocol A2ALL: Adult-to-Adult Living Transplant Cohort Study Not Specified Other Not Applicable
Displaying: 1 - 8 of 8 Results
  • < Previous
  • 1
  • Next >